RecruitingNot ApplicableNCT06721065

A Study of Language Interpretation Solutions for People With Breast Cancer

RSMI HEALS (Health Equity Advances Through Language Solutions) (AI)


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

700 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing different language interpretation approaches — such as professional interpreters versus AI-based tools — during oncology appointments for cancer patients who speak Spanish or Mandarin and have limited English proficiency. The goal is to improve communication and care quality for patients who face language barriers. **You may be eligible if...** - You are 18 years or older - You prefer to speak Spanish or Mandarin for your healthcare conversations - You cannot speak English well - You have been diagnosed with breast or gastrointestinal cancer - You are attending your first or second appointment with the oncology team at the study site - You agree to have your appointment audio-recorded **You may NOT be eligible if...** - You have significant psychiatric disturbance that prevents you from giving informed consent or completing assessments - You have cognitive impairment (such as dementia or delirium) that would prevent meaningful participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRemote Simultaneous Medical Interpreting/RSMI

Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter, which holds tremendous promise for closely approximating a same language encounter, decreasing interpreting errors, and improving outcomes.

OTHERRemote Consecutive Medical Interpreting/RCMI

Remote Consecutive Medical Interpreting (RCMI; "audio consecutive"), is the most commonly utilized remote interpreting

OTHERRemote Consecutive Video Medical Interpreting/RCVI

Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter


Locations(8)

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk- Commack (Consent Only)

Commack, New York, United States

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, United States

Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)

New York, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Memorial Sloan Kettering Nassau (All Protocol Activities)

Rockville Centre, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06721065


Related Trials